TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Jacobson Pharma Corporation Limited ( (HK:2633) ).
Jacobson Pharma Corporation Limited has announced its upcoming annual general meeting to be held virtually on July 28, 2025. Key agenda items include the approval of financial statements, declaration of final and special dividends, re-election of directors, and the reappointment of KPMG as auditor. Additionally, the company seeks shareholder approval for a mandate to repurchase up to 10% of its issued shares, which could impact the company’s stock liquidity and shareholder value.
More about Jacobson Pharma Corporation Limited
Jacobson Pharma Corporation Limited is a pharmaceutical company incorporated in the Cayman Islands, focusing on the development, production, and distribution of generic drugs and proprietary medicines. It operates primarily in the healthcare industry, serving markets with a range of pharmaceutical products.
Average Trading Volume: 1,286,846
Technical Sentiment Signal: Buy
Current Market Cap: HK$3.1B
See more data about 2633 stock on TipRanks’ Stock Analysis page.